GM1
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for GM1, covering 2014-01-07 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer [Phase 3]